Search
Integra Lifesciences Holdings Corp
IARTAdd to Watchlist
15.710USD
+0.210+1.35%
Close 09-14 16:00（ET）
1.22BMarket Cap
LossP/E TTM
Integra Lifesciences Holdings Corp (IART) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Integra Lifesciences Holdings Corp in the past month.
Hold
2 Strong Buy
1 Buy
6 Hold
2 Sell
0 Strong Sell
Target Price
19.875USD+28.23%
IART Analyst Recommendation Trends
In the current month, IART has received 1 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. IART average Analyst price target in the last month is 19.875.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
1
2
2
2
2
2
1
1
1
1
1
1
1
1
6
6
6
5
5
5
5
5
0
0
1
1
1
1
1
1
2
2
2
2
3
3
3
3
11
11
11
11
12
12
12
12
IART Analyst Rating for Peer Comparison
Updated: Sep 14, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
11
10
0
0
30
Abbott Laboratories
ABT
11
12
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Guardant Health Inc
GH
12
14
2
0
0
28
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Insulet Corp
PODD
10
12
5
0
0
27
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
14
3
0
0
22
Financial Forecasting
Based on analysts' estimates, IART EPS is projected to reach 0.563 in FY2026Q3, following reported EPS of 0.058 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.80
0.40
0.48
0.56
0.80
Actual
-0.02
-0.06
0.06
--
--
Surprise
-102.77%
-114.83%
-88.00%
--
--
FAQs
What is Integra Lifesciences Holdings Corp's expected revenue for the next quarter?
Integra Lifesciences Holdings Corp's expected revenue is 416.31M.
What is Integra Lifesciences Holdings Corp's price target?
Analysts forecast that Integra Lifesciences Holdings Corp's price target is USD 19.88, with the highest forecast at USD 27.00 and the lowest forecast at USD 14.00.
How have Integra Lifesciences Holdings CorpIART's recent earnings per share performed?
The market expectation was USD 0.06, while Integra Lifesciences Holdings CorpIART's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD 0.56.
What is the analyst rating for Integra Lifesciences Holdings Corp?
Based on the ratings of Integra Lifesciences Holdings Corp's stock from 11 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.